SouthState Corp’s Avanos Medical AVNS Stock Holding History

SouthState Corp’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18	Closed	-$535	–	594
2023 Q1	$535	Hold	18	–	–	﹤0.01%	629
2022 Q4	$487	Buy	+18	New	+$440	﹤0.01%	682

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SouthState Corp's AVNS Position: Q2 2023 in Review

SouthState Corp sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 18 shares — an estimated $535 sold.

SouthState Corp first reported a position in AVNS in Q4 2022 and held it in 2 quarters. The position peaked at $535 in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

SouthState Corp reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
SouthState Corp sold 18 Avanos Medical shares in Q2 2023, an estimated $535.
SouthState Corp first reported a position in Avanos Medical in Q4 2022 and held it in 2 quarters.
SouthState Corp's Avanos Medical position peaked at $535 in Q1 2023.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on SouthState Corp's 13F filing for Q2 2023, filed 8 Aug 2023.